Interaction between group A streptococci and the plasmin(ogen) system promotes virulence in a mouse skin infection model

Journal of Infectious Diseases

Volumn 179, Issue 4, 1999, Pages 907-914

  Li, Zhuqing ^a   Ploplis, Victoria A ^c   French, Esther L ^c   Boyle, Michael D P ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN;

ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; ENZYME ACTIVITY; FEMALE; MOUSE; NEWBORN; NONHUMAN; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A;

EID: 0032943571     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314654     Document Type: Article

References (37)

1. Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med 1996; 334:240-5.
2. Stevens DL. Group A streptococcus: from basic science to clinical disease. West J Med 1996; 164:25-7.
3. Schlievert PM, Assomacopoulos AP, Cleary PP. Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J Lab Clin Med 1996; 127:13-22.
4. Cone LA, Woodward DR, Schlievert PM, Tomory GS. Clinical bacteriological observations of a toxic shock like syndrome due to Streptococcus pyogenes. N Engl J Med 1987; 317:146-9.
5. Stevens DL, Tanner MH, Wiship J, et al. Severe group A Streptococcal infections associated with a toxic shock like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-7.
6. Cleary PP, Kaplan EL, Handley JP, et al. Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s. Lancet 1992; 339: 518-21.
7. Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, Selandr RK. Streptococcus pyogenes causing toxin-shock-like syndrome and other in vasive diseases: clonal diversity and pyrogenic toxin expression. Proc Natl Acad Sci USA 1991; 88:2668-72.
8. Holm SE, Norrby A, Bergholm AM, Morgen M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1992; 166:31-7.
9. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group. N Engl J Med 1996; 335:547-54.
10. Lottenberg R, Broder CC, Boyle MDP. Identification of a specific receptor for plasmin on a group A streptococcus. Infect Immun 1987; 55:1914-28.
11. Lottenberg R, DesJardin LE, Wang H, Boyle MDP. Streptokinase-producing streptococci grown in human plasma acquire unregulated cell-associated plasmin activity. J Infect Dis 1992; 166:436-40.
12. Boyle MDP, Lottenberg R. Plasminogen activation by invasive human pathogens. Thromb Haemost 1997; 77:1-10.
13. Lottenberg R, Minning-Wenz D, Boyle MDP. Capturing host plasmi(ogen): a common mechanism for invasive pathogen? Trends Microbiol 1994; 2: 20-4.
14. Wang H, Lottenberg R, Boyle MDP. A role of fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci. J Infect Dis 1995; 171:85-92.
15. Christner R, Li ZQ. Raeder R, Podbielski A, Boyle MDP. Identification of key gene products required for acquisition of plasmin-like enzymatic activity by group A streptococci. J Infect Dis 1997; 175:1115-20.
16. Wang H, Lottenberg R, Boyle MDP. Analysis of the interaction of group A streptococci with fibrinogen, streptokinase, and plasminogen. Microb Pathog 1995; 18:153-66.
17. D'Costa S, Boyle MDP. Interaction of a group A streptococcus within human plasma results in assembly of a surface plasminogen activator that contributes to occupancy of surface plasmin-binding structures. Microb Pathog 1998; 24:341-9.
18. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 1985; 44:139-266.
19. Strickland S, Reich E, Sherman MI. Plasminogen activator in early cmbryogenesis: enzyme production by trophoblast and parietal endoderm. Cell 1976; 9:231-40.
20. Boyle MDP, Lawman MJ, Gee AP, Young M. Measurement of leucocyte chemotaxis in vivo. Methods Enzymol 1988; 162:101-14.
21. Raeder R, Boyle MDP. Association between expression of immunoglobulin G binding proteins by group A streptococci and virulence in a mouse skin infection model. Infect Immun 1993; 61:1378-84.
22. Broder CC, Lottenberg R, Boyle MDP. Mapping of the human plasmin domain recognized by the unique plasmin receptor of group A streptococci. Infect Immun 1989; 57:2597-605.
23. Wulf RJ, Mentz ET. Studies on plasminogen. VIII. Species specificity of streptokinase. Can J Biochem 1969; 47:927-31.
24. Kulisek F.S. Holm SE, Johnston KH. A chromogenic assay for the detection of plasmin generated by plasminogen activator immobilized on nitrocellulose using para-nitroanalide synthetic peptide substrate. Anal Biochem 1989; 177:78-84.
25. Wang H, Lottenberg R, Boyle MDP. Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma. J Infect Dis 1994; 169:143-9.
26. Ploplis VA, Carmeliet P, Vazirzudeh S, et al. Effects of disruption of the plasminogen gene on thrombosis, growth, and health in mice. Circulation 1995; 92:2585-93.
27. Reddy KNN, Markus G. Mechanism of activation of human plasminogen by streptokinase. J Biol Chem 1972; 247:1683-91.
28. Marcum JA, Kline DL. Species specificity of streptokinase. Comp Biochem Physiol [B] 1983; 75:389-94.
29. Bugge TH, Flick MH, Daugherty CC, Degen JL. Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Dev 1995; 9:794-807.
30. Ploplis VA, French EL, Carmeliet P, Collen D, Plow EF. Plasminogen deficiency differentially affects recruitment of inflammatory cell populations in mice. Blood 1998; 91:2005-9.
31. Carmeliet P, Collen D. Genetic analysis of the plasminogen and coagulation system in mice. Haemostasis 1996; 26(suppl 4):132-53.
32. Lijnen HR, Carmeliet P, Bouche A, et al. Restoration of thrombolytic potential in plasminogen-deficient mice by bolus administration of plasminogen. Blood 1996; 88:870-6.
33. Carmeliet P, Collen D. Gene targeting and gene transfer studies of the biological role of the plasminogen/plasmin system. Thromb Haemost 1995; 74:429-36.
34. Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL. Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 1997; 89:1111-9.
35. Sodeinde OA, Subrahmanyam YV, Stark K, Quan T, Bao Y, Goguen JD. A surface protease and the invasive character of plaque. Science 1992; 258:1004-7.
36. Goguen JD, Hoe NP, Scheiman HL, et al. Plasminogen-deficient mice have increased resistance to plaque [abstract]. In: Microbes, Haemostasis, and Vascular Biology (Galveston, TX). Washington, DC: American Society for Microbiology, 1998.
37. Gyetko MR, Chen GH, McDonald RA, et al. Urokinase is required of the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model. J Clin Invest 1996; 97:1818-26.